Literature DB >> 19214712

Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: the role of peroxidative damage and antioxidative enzymes.

Prachi Mishra1, Anand Kar, Raosaheb K Kale.   

Abstract

Isoflavones are biologically active plant derived compounds that have several health promoting effects. In the present study hitherto unknown effects of one of the well known isoflavonoids, daidzein, has been evaluated on its chemo-preventive action against breast cancers in pre-pubertal rats. Either daidzein (500 mug/g bwt) or vehicle, dimethyl sulphoxide (DMSO), was administered at 16th, 18th, and 20th day post-partum and the chemopreventive efficacy was evaluated in dimethylbenz[a]nthracene (DMBA) induced Sprague-Dawley rats, at 50th day. To elucidate the mechanism of action, the antioxidative status was also examined in the liver and mammary gland of prebubertal rats using two different doses of daidzein (0.5 mg/kg bwt and 50 mg/kg bwt, p.o.) for 10 days. The specific activity of antioxidant enzymes as well as reduced glutathione (GSH) level and peroxidative damage were evaluated spectrophotometrically, both in liver as well as in mammary gland. Animals treated with daidzein pre-pubertally, showed a significant reduction in the tumorigenesis of mammary gland up to 37.4% as compared to animals induced for tumors with DMBA. In animals treated with 50 mg/kg of daidzein, a significant increase in the specific activities of the antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione transferase (GST), DT-diaphorase (DTD), and in GSH content were observed in both liver and mammary gland. Expectedly, the specific activity of lactate dehydrogenase (LDH) and level of peroxidative damage was decreased, as compared to that of control group of animals. Our results suggest that, daidzein can be considered as a potent chemopreventive agent against mammary carcinogenesis in pre-pubertal animals, with modulation of antioxidant enzymes being one of its mechanisms of actions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214712     DOI: 10.1007/s11010-009-0029-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  56 in total

1.  Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women.

Authors:  X O Shu; F Jin; Q Dai; W Wen; J D Potter; L H Kushi; Z Ruan; Y T Gao; W Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

2.  Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones.

Authors:  A I Constantinou; R G Mehta; A Vaughan
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

3.  Exposure of infants to phyto-oestrogens from soy-based infant formula.

Authors:  K D Setchell; L Zimmer-Nechemias; J Cai; J E Heubi
Journal:  Lancet       Date:  1997-07-05       Impact factor: 79.321

4.  Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors.

Authors:  Hiroko Usami; Yuri Kusano; Takeshi Kumagai; Shigehiro Osada; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Koji Uchida
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

Review 5.  Soy proteins and cardiovascular disease.

Authors:  C R Sirtori; M R Lovati
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

6.  GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?

Authors:  P J Bastian; J Ellinger; D Schmidt; N Wernert; A Wellmann; S C Müller; A von Rücker
Journal:  Eur J Med Res       Date:  2004-11-29       Impact factor: 2.175

7.  The possible role of lipid peroxidation in breast cancer risk.

Authors:  N F Boyd; V McGuire
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

8.  Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein.

Authors:  H Wei; L Wei; K Frenkel; R Bowen; S Barnes
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

9.  Sex hormones in women in rural China and in Britain.

Authors:  T J Key; J Chen; D Y Wang; M C Pike; J Boreham
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

10.  Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.

Authors:  Z Lian; K Niwa; K Tagami; M Hashimoto; J Gao; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  2001-07
View more
  4 in total

Review 1.  Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals.

Authors:  Maria H Traka; Richard F Mithen
Journal:  Plant Cell       Date:  2011-07-29       Impact factor: 11.277

2.  Genistein and daidzein, in combination, protect cellular integrity during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats.

Authors:  Pachaiappan Pugalendhi; Shanmugam Manoharan; Kathiresan Suresh; Nagarethinam Baskaran
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

3.  Androgen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein.

Authors:  Abdul Lateef; Abdul Quaiyoom Khan; Mir Tahir; Rehan Khan; Muneeb U Rehman; Farrah Ali; Oday O Hamiza; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2012-11-08       Impact factor: 3.396

4.  Prepubertal daidzein exposure enhances mammary gland differentiation and regulates the expression of estrogen receptor-alpha and apoptotic proteins.

Authors:  Prachi Mishra; Anand Kar; R K Kale
Journal:  ISRN Oncol       Date:  2011-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.